Reduction mammaplasty: an outcome analysis.

Breast reduction surgery in the UK and Ireland - current trends. Ann R Coll Surg Engl (2006) 0.87

The effect of breast hypertrophy on patient posture. Arch Plast Surg (2013) 0.84

Effects of breast reduction on pulmonary function. Int Surg (2014) 0.75

Unfavourable results following reduction mammoplasty. Indian J Plast Surg (2013) 0.75

Risk Factors for Complications after Reduction Mammoplasty: A Meta-Analysis. PLoS One (2016) 0.75

Four flap suspension technique for prevention of bottoming out after breast reduction. Ann Surg Treat Res (2015) 0.75

Re: Reduction mammaplasty: an outcome analysis. Ann Plast Surg (1996) 0.75

Cosmetic and reconstructive breast surgery in adolescents: psychological, ethical, and legal considerations. Semin Plast Surg (2013) 0.75

Comparison of surgical conditions in 2 different anesthesia techniques of esmolol-induced controlled hypotension in breast reduction surgery. Medicine (Baltimore) (2017) 0.75

A signature motif in transcriptional co-activators mediates binding to nuclear receptors. Nature (1997) 11.15

Rescue of early embryonic lethality in mdm2-deficient mice by deletion of p53. Nature (1995) 10.18

A modified oestrogen receptor ligand-binding domain as an improved switch for the regulation of heterologous proteins. Nucleic Acids Res (1995) 7.95

Fatty acids, eicosanoids, and hypolipidemic agents identified as ligands of peroxisome proliferator-activated receptors by coactivator-dependent receptor ligand assay. Mol Endocrinol (1997) 4.71

Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors. EMBO J (1992) 4.69

Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor. EMBO J (1995) 4.23

Environmentally persistent alkylphenolic compounds are estrogenic. Endocrinology (1994) 4.10

A variety of environmentally persistent chemicals, including some phthalate plasticizers, are weakly estrogenic. Environ Health Perspect (1995) 3.47

Characterization and colocalization of steroid binding and dimerization activities in the mouse estrogen receptor. Cell (1990) 3.37

Interaction of proteins with transcriptionally active estrogen receptors. Proc Natl Acad Sci U S A (1994) 3.10

HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cells. Oncogene (1995) 2.84

Clinical study of forty-nine patients with malignant melanoma. Cancer (1966) 2.74

Identification of two transactivation domains in the mouse oestrogen receptor. Nucleic Acids Res (1989) 2.70

Relative analgesic potencies of ropivacaine and bupivacaine for epidural analgesia in labor: implications for therapeutic indexes. Anesthesiology (1999) 2.64

Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions. Mol Endocrinol (1994) 2.62

POU domain factor Brn-3b is required for the development of a large set of retinal ganglion cells. Proc Natl Acad Sci U S A (1996) 2.48

Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor. EMBO J (1998) 2.44

Estrogen receptors alpha and beta form heterodimers on DNA. J Biol Chem (1997) 2.39

Identification of residues in the estrogen receptor that confer differential sensitivity to estrogen and hydroxytamoxifen. Mol Endocrinol (1993) 2.37

Genetic analysis of digestive physiology using fluorescent phospholipid reporters. Science (2001) 2.36

The antiestrogen ICI 182780 disrupts estrogen receptor nucleocytoplasmic shuttling. J Cell Sci (1993) 2.04

Inhibition of estrogen receptor-DNA binding by the "pure" antiestrogen ICI 164,384 appears to be mediated by impaired receptor dimerization. Proc Natl Acad Sci U S A (1990) 2.03

17beta-Estradiol induces cyclin D1 gene transcription, p36D1-p34cdk4 complex activation and p105Rb phosphorylation during mitogenic stimulation of G(1)-arrested human breast cancer cells. Oncogene (1996) 2.01

The AF1 and AF2 domains of the androgen receptor interact with distinct regions of SRC1. Mol Cell Biol (1999) 2.00

Antiestrogen ICI 164,384 reduces cellular estrogen receptor content by increasing its turnover. Proc Natl Acad Sci U S A (1992) 1.96

The estrogenic activity of phthalate esters in vitro. Environ Health Perspect (1997) 1.94

Inhalation anaesthetics and climate change. Br J Anaesth (2010) 1.90

Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein. Mol Cell Biol (1995) 1.77

Use of a purified outer membrane protein F (porin) preparation of Pseudomonas aeruginosa as a protective vaccine in mice. Infect Immun (1984) 1.75

Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol (1993) 1.72

Identification of novel oestrogen receptor target genes in human ZR75-1 breast cancer cells by expression profiling. J Mol Endocrinol (2001) 1.59

Functional interaction between the p160 coactivator proteins and the transcriptional enhancer factor family of transcription factors. J Biol Chem (2000) 1.59

A consensus DNA-binding site for the androgen receptor. Mol Endocrinol (1992) 1.59

Dose-dependent reduction of the minimum local analgesic concentration of bupivacaine by sufentanil for epidural analgesia in labor. Anesthesiology (1998) 1.58

AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors. Mol Cell Biol (1997) 1.58

Differential effects of xenoestrogens on coactivator recruitment by estrogen receptor (ER) alpha and ERbeta. J Biol Chem (2000) 1.54

Molecular determinants of the estrogen receptor-coactivator interface. Mol Cell Biol (1999) 1.46

RIP-140 interacts with multiple nuclear receptors by means of two distinct sites. Mol Cell Biol (1996) 1.39

Regulation of gene expression by nuclear hormone receptors. Curr Opin Cell Biol (1989) 1.37

Rat prostatic steroid binding protein: DNA sequence and transcript maps of the two C3 genes. EMBO J (1983) 1.35

An outcomes analysis and satisfaction survey of 199 consecutive abdominoplasties. Ann Plast Surg (2001) 1.33

A comparison of transcriptional activation by ER alpha and ER beta. J Steroid Biochem Mol Biol (1999) 1.31

Gallstone pancreatitis: a prospective randomized trial of the timing of surgery. Surgery (1988) 1.30

Core LXXLL motif sequences in CREB-binding protein, SRC1, and RIP140 define affinity and selectivity for steroid and retinoid receptors. J Biol Chem (2000) 1.29

Crouzon syndrome: mutations in two spliceoforms of FGFR2 and a common point mutation shared with Jackson-Weiss syndrome. Hum Mol Genet (1995) 1.25

Mutations in the estrogen receptor ligand binding domain discriminate between hormone-dependent transactivation and transrepression. J Biol Chem (2000) 1.22

Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists. Proc Natl Acad Sci U S A (1995) 1.19

Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer. Oncogene (2000) 1.18

A secretory protease inhibitor requires androgens for its expression in male sex accessory tissues but is expressed constitutively in pancreas. EMBO J (1987) 1.18

Effects of androgens on the complexity of poly(A) RNA from rat prostate. Cell (1977) 1.17

Lung herniation into the neck associated with congenital absence of the sternocleidomastoid muscle. J Pediatr Surg (1997) 1.16

Hormonal regulation of protein synthesis in the rat epididymis. Characterization of androgen-dependent and testicular fluid-dependent proteins. Biochem J (1980) 1.16

Median cleft of the lower lip and mandible: a case report. Br J Plast Surg (1971) 1.15

Testosterone regulates the synthesis of major proteins in rat ventral prostate. Biochem J (1978) 1.14

Ligand-independent activation of the oestrogen receptor by mutation of a conserved tyrosine. EMBO J (1997) 1.13

Prostatic steroid-binding protein. Isolation and characterization of C3 genes. J Biol Chem (1983) 1.12

Androgen-regulated expression of a cloned rat prostatic c3 gene transfected into mouse mammary tumor cells. Cell (1983) 1.12

A 22-amino-acid peptide restores DNA-binding activity to dimerization-defective mutants of the estrogen receptor. Mol Cell Biol (1990) 1.11

Earlobe composite grafts for the correction of nasal defects. Plast Reconstr Surg (1971) 1.10

A natural transactivation mutation in the thyroid hormone beta receptor: impaired interaction with putative transcriptional mediators. Proc Natl Acad Sci U S A (1997) 1.10

Cloning and characterization of androgen-dependent mRNA from rat ventral prostate. J Biol Chem (1980) 1.09

Management of dog bite avulsions of the lip vermilion. Pediatr Emerg Care (1986) 1.09

LIVING FASCIAL SUTURE IN THE REPAIR OF LARGE INGUINAL HERNIAE. Ann Surg (1940) 1.08

Nuclear receptors spring into action. Nat Struct Biol (1996) 1.08

Mechanism of estrogen receptor-dependent transcription in a cell-free system. Mol Cell Biol (1990) 1.07

Peptide growth factor cross-talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology (1996) 1.06

Self-association of a synthetic peptide from the N terminus of the hepatitis delta virus protein into an immunoreactive alpha-helical multimer. Proc Natl Acad Sci U S A (1995) 1.05

Socioeconomic status, marital status and hip fracture risk: a population-based case-control study. Osteoporos Int (2000) 1.04

Blood gases and acid-base values of unanesthetized rats exposed to hypoxia. Am J Physiol (1967) 1.04

Mechanisms of androgen receptor activation in advanced prostate cancer: differential co-activator recruitment and gene expression. Oncogene (2007) 1.04

CAAT/enhancer binding protein is able to bind to ATF/CRE elements. Nucleic Acids Res (1991) 1.02

Effects of testosterone on sequence complexity of polyadenylated RNA from rat seminal vesicle. Eur J Biochem (1978) 1.01

Isotope or mass encoding of combinatorial libraries. Chem Biol (1996) 1.00

Malignancy and chronic wounds: Marjolin's ulcer. J Burn Care Rehabil (1991) 1.00

Characterization of ligand-dependent phosphorylation of the estrogen receptor. Mol Endocrinol (1994) 1.00

Functional estrogen receptors in osteoblastic cells demonstrated by transfection with a reporter gene containing an estrogen response element. Mol Endocrinol (1991) 0.99

1,4-Bis[2-(3,5-dichloropyridyloxy)]benzene, an extremely potent modulator of mouse hepatic cytochrome P-450 gene expression. Biochem J (1993) 0.98

The prevalence of pain among the oldest old in Sweden. Pain (1996) 0.97

Prevention of abdominal wound disruption. Surg Gynecol Obstet (1968) 0.97

COUP-TF II homodimers are formed in preference to heterodimers with RXR alpha or TR beta in intact cells. Nucleic Acids Res (1995) 0.96

Interplay between estrogens, progestins, retinoic acid and AP-1 on a single regulatory site in the progesterone receptor gene. J Biol Chem (1994) 0.96

Regulation of prostatic steroid binding protein mRNAs by testosterone. Mol Cell Endocrinol (1985) 0.96

The androgenic regulation of abundant mRNA in rat ventral prostate. Eur J Biochem (1978) 0.96

Mobility limitations in the Swedish population from 1968 to 1992: age, gender and social class differences. Aging (Milano) (2000) 0.94

Cross-talk between Stat5b and estrogen receptor-alpha and -beta in mammary epithelial cells. J Mol Endocrinol (2001) 0.94

Analysis of the aromatase cytochrome P450 gene in human breast cancers. J Mol Endocrinol (1994) 0.93

Effect of androgen on the transcription of rat prostatic binding protein genes. Mol Cell Endocrinol (1982) 0.93

Androgen-regulated expression of secretory protein synthesis in mouse ventral prostate. Mol Cell Endocrinol (1987) 0.93

Tissue-specific and hormonal regulation of the gene for rat prostatic steroid-binding protein in transgenic mice. Mol Cell Biol (1989) 0.93

Does infection play a role in breast capsular contracture? Plast Reconstr Surg (1981) 0.92

Androgenic regulation of messenger RNA in rat epididymis. Biochem J (1980) 0.92

Priorities in care and services for elderly people: a path without guidelines? J Med Ethics (2000) 0.92

Presence of a phospholipase D (PLD) distinct from PLD1 or PLD2 in human neutrophils: immunobiochemical characterization and initial purification. Biochim Biophys Acta (2001) 0.91

Generation and detection of plasmonic nanobubbles in zebrafish. Nanotechnology (2010) 0.90

Effect of H1- and H2-receptor blockade on the inhibition of immediate cutaneous reactions. Clin Pharm (1984) 0.90

Orthognathic surgery in the cleft lip and palate patient. Clin Plast Surg (1993) 0.90

Identification of phosphorylation sites in the mouse oestrogen receptor. J Steroid Biochem Mol Biol (1995) 0.89

Conditionally immortalized white preadipocytes: a novel adipocyte model. J Lipid Res (2007) 0.89